Interaction of fluoxetine with tricyclic antidepressants.

Suppr

超能文献

作者信息

Vaughan D A

出版信息

Am J Psychiatry. 1988 Nov;145(11):1478. doi: 10.1176/ajp.145.11.1478b.

DOI:10.1176/ajp.145.11.1478b

PMID:3263809

Abstract

摘要

相似文献

Interaction of fluoxetine with tricyclic antidepressants.

Am J Psychiatry. 1988 Nov;145(11):1478. doi: 10.1176/ajp.145.11.1478b.

Serious adverse effects of combining fluoxetine and tricyclic antidepressants.

Am J Psychiatry. 1990 Apr;147(4):532. doi: 10.1176/ajp.147.4.532a.

[Fluoxetine and tricyclic antidepressants: clinical tolerance in short-term combined administration].

Encephale. 1996 May-Jun;22(3):221-7.

Fluoxetine-imipramine interaction.

Can J Psychiatry. 1996 Jun;41(5):318-9. doi: 10.1177/070674379604100515.

Increased plasma tricyclic antidepressant concentrations in two patients concurrently treated with fluoxetine.

J Clin Psychiatry. 1989 Jun;50(6):226-7.

Tricyclic antidepressant plasma levels after fluoxetine addition.

Neuropsychobiology. 1992;25(4):202-7. doi: 10.1159/000118838.

Fluoxetine and elevated plasma levels of tricyclic antidepressants.

Am J Psychiatry. 1990 Sep;147(9):1251. doi: 10.1176/ajp.147.9.1251b.

Fatality associated with combined fluoxetine-amitriptyline therapy.

JAMA. 1997 Jun 4;277(21):1682. doi: 10.1001/jama.1997.03540450038031.

Tianeptine versus fluoxetine in the treatment of depression complicating Alzheimer's disease.

Int J Geriatr Psychiatry. 2001 Nov;16(11):1108-9. doi: 10.1002/gps.457.

[Toxic tricyclic drug plasma level caused by fluoxetine].

Psychiatr Prax. 1995 Nov;22(6):252-3.

引用本文的文献

Clinical pharmacokinetics of sertraline.

Clin Pharmacokinet. 2002;41(15):1247-66. doi: 10.2165/00003088-200241150-00002.

Clinically significant drug interactions with antidepressants in the elderly.

Drugs Aging. 2002;19(4):299-320. doi: 10.2165/00002512-200219040-00004.

Therapeutic drug monitoring databases for postmarketing surveillance of drug-drug interactions.

Drug Saf. 2001;24(13):947-59. doi: 10.2165/00002018-200124130-00002.

Risk of adverse events with the use of augmentation therapy for the treatment of resistant depression.

Drug Saf. 1998 Dec;19(6):455-64. doi: 10.2165/00002018-199819060-00003.

Selective serotonin reuptake inhibitors and CNS drug interactions. A critical review of the evidence.

Clin Pharmacokinet. 1997 Dec;33(6):454-71. doi: 10.2165/00003088-199733060-00004.

Drug interactions of clinical significance with selective serotonin reuptake inhibitors.

Drug Saf. 1997 Dec;17(6):390-406. doi: 10.2165/00002018-199717060-00005.

Tricyclic antidepressant plasma levels after augmentation with citalopram: a case study.

Eur J Clin Pharmacol. 1993;44(4):403-5. doi: 10.1007/BF00316483.

Clinical pharmacokinetics of fluoxetine.

Clin Pharmacokinet. 1994 Mar;26(3):201-14. doi: 10.2165/00003088-199426030-00004.

Comparative tolerability profiles of the newer versus older antidepressants.

Drug Saf. 1994 Jan;10(1):18-46. doi: 10.2165/00002018-199410010-00003.

The pharmacogenetics of the selective serotonin reuptake inhibitors.

Clin Investig. 1993 Dec;71(12):1002-9. doi: 10.1007/BF00180032.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验